India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.

via Reuters: Health News Read More Here..